London/New Delhi/São Paulo — On a balmy day in January on the outskirts of Pune, a city of 3-million people in Maharashtra state, women in saris are sitting on plastic chairs under a humming fan waiting for their first shot of Covishield, as the Oxford-AstraZeneca Covid-19 vaccine is known in India.

Wearing a white doctor’s coat, Dr Varsha Gaekwad, who is overseeing the first immunisations of front-line health-care workers in the country of nearly 1.4-billion people, says it will take time for the public to gain confidence in the vaccine. “Once the health workers are going ahead with it, that means it’s 100% safe,” she says. “That is what the community will see.”..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now